Larvol Delta - Catamaran-Bio-Presents-Preclinical-In-Vivo-Efcacy-Data-Supporting-Advancement-of-CAT179-a-HER2targeted-Allogeneic-CARNK-Cell-Therapy

CAT-179 - Catamaran Bio

https://www.businesswire.com/news/home/20220408005050/en/Catamaran-Bio-Presents-Preclinical-In-Vivo-Efficacy-Data-Supporting-Advancement-of-CAT%E2%80%91179-a-HER2-targeted-Allogeneic-CAR-NK-Cell-Therapy

Apr 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next